- Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences
NEW YORK, Oct. 30, 2014 /PRNewswire/ -- Atlas Genetics, an in vitro diagnostics company that has developed an ultra-rapid point-of-care molecular diagnostic system for infectious disease testing, announced today it has been selected to present at the Oxford University hosted Cavendish Global Health Impact Forum taking place Monday, November 10th to Thursday, November 13th at Oxford University in the UK. The purpose of the Forum is to help leading family offices and foundations from around the world develop and implement their individual impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. Michael Moffat, Cavendish co-founder and President explains, "With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of Atlas Genetics' research and scientific insights in rapid, point-of-care diagnostics positions them to make a major contribution to infectious disease testing in the future"
"We are honored to be selected to present at this unique event, and it is further recognition of our innovative approach to transforming infectious disease testing. Our new diagnostics system provides on-demand, actionable tests results for diseases such as sexually transmitted infections and hospital acquired infections, enabling immediate, effective, treatment and control", said John Clarkson, Chief Executive Officer of Atlas Genetics, headquartered in Trowbridge, Wiltshire, England. "We welcome the chance to interact with many of world's leading scientific minds, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world."
Cavendish Global consists of over 150 leading family offices and foundations from around the world with combined assets of over $190 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world.
About Atlas Genetics
Atlas Genetics Ltd develops ultra-rapid decentralised and point-of-care (POC) diagnostic tests for infectious diseases. The Atlas io™ system uses patented technology based on the use of a novel electrochemical sensor that combines speed, accuracy and multiplex detection capability. The Company has its head office and laboratory facilities near Bath, UK. Atlas was established in 2005 and is financed by VC, corporate and private investors including Novartis Venture Funds, Consort Medical plc, J&J Development Corporation, Life Science Partners (LSP) BB Biotech Ventures and Technology Venture Partners.
For more information: www.atlasgenetics.com
John Clarkson, Chief Executive Officer, Atlas Genetics Ltd.
About Cavendish Global
Cavendish Global provides leading family offices and their foundations from around the world with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual impact investment, grant-giving and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative advisory and digital resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Forums take place three times each year and are hosted by leading institutions around the world. In May of 2014 the Cavendish Global Health Impact Forum was hosted at the United Nations Headquarters, Secretariat Building New York, The Rockefeller University and The New York Academy of Sciences. Following the Oxford University hosted Cavendish Forum in November of tis year, the Cavendish community of family offices will next convene in the spring of 2015 in the United States.
For more information: http://cavendishglobal.com
President, Strategic Alliances, Cavendish Global
Direct Line: +1-917-576-1435
SOURCE Cavendish Global